Goldman Sachs Group Inc. cut its holdings in Arteris, Inc. (NASDAQ:AIP - Free Report) by 35.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,546 shares of the company's stock after selling 40,885 shares during the period. Goldman Sachs Group Inc. owned approximately 0.18% of Arteris worth $508,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the business. Acadian Asset Management LLC raised its holdings in Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after buying an additional 260,277 shares in the last quarter. AQR Capital Management LLC acquired a new position in shares of Arteris during the 1st quarter valued at about $1,621,000. Federated Hermes Inc. raised its stake in shares of Arteris by 97.2% in the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock valued at $2,260,000 after acquiring an additional 161,241 shares in the last quarter. Next Century Growth Investors LLC raised its stake in shares of Arteris by 46.4% in the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock valued at $2,817,000 after acquiring an additional 129,143 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Arteris by 56.5% in the 4th quarter. Millennium Management LLC now owns 238,309 shares of the company's stock worth $2,428,000 after purchasing an additional 85,996 shares during the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Stock Down 2.1%
Shares of AIP stock opened at $9.84 on Friday. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $14.29. The firm has a market cap of $419.68 million, a PE ratio of -12.00 and a beta of 1.44. The stock has a 50 day moving average of $9.54 and a 200-day moving average of $8.30.
Arteris (NASDAQ:AIP - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). The business had revenue of $16.50 million for the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts predict that Arteris, Inc. will post -0.73 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages have commented on AIP. Wall Street Zen upgraded Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. TD Cowen raised their target price on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $15.00.
Get Our Latest Analysis on AIP
Insider Buying and Selling at Arteris
In related news, CFO Nicholas B. Hawkins sold 11,276 shares of the stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.15, for a total value of $148,279.40. Following the completion of the sale, the chief financial officer owned 107,996 shares in the company, valued at approximately $1,420,147.40. This trade represents a 9.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total value of $656,000.00. Following the sale, the insider directly owned 9,839,071 shares in the company, valued at approximately $129,088,611.52. This trade represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 470,911 shares of company stock valued at $5,573,464 in the last three months. Company insiders own 29.10% of the company's stock.
Arteris Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.